USMF WisdomTree U.S. Multifactor Fund

WisdomTree U.S. Multifactor Fund (USMF) currently reports 200 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is WDC (1.49%), VRSN (1.43%), CSCO (1.42%), with WDC as the largest single weight at 1.49%. Together, the top three holdings account for 4.34%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Looking at how effectively the underlying holdings deploy capital, ROIC is 23.33%, WACC is 7.88%, and the economic spread is 15.46%. On balance, returns on invested capital exceed the cost of funding by a comfortable margin, which over time compounds favorably for long-term holders. Supporting metrics show ROE at 29.61% and ROA at 8.27%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

From a pricing standpoint, the portfolio sits at trailing P/E of 18.77, forward P/E of 14.24, PEG of 1.99. The narrow spread between trailing and forward multiples implies earnings expectations are relatively stable — the portfolio is not being priced for an earnings inflection. The growth-adjusted multiple is neither a strong buy signal nor a clear warning — it sits in the range where execution quality will determine whether the price is ultimately justified. A current ratio reading of 2.65 suggests the portfolio's businesses are well-capitalized for near-term needs. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.

Across the three margin layers, gross margin sits at 53.28%, operating margin at 23.78%, and free cash flow margin at 20.62%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.

Two key indicators frame the near-term view: TTM revenue growth of 11.72% a signal of steady demand without the volatility of high-growth names, while the estimated 12-month price change of 18.65%, where the target distribution indicates incremental upside rather than outsized repricing. The near-term return case is built on whether reported trends and analyst projections can remain close enough to make current prices look justified. Whether the setup resolves positively or negatively will depend as much on the macro backdrop as on the capacity of the underlying businesses to deliver against current estimates. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The full scorecard here is hard to argue with: capital efficiency is strong, margins are healthy, and growth is being priced constructively.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.